| ［1］ |
Wen Y, Liu Y, Xu Y, et al. Loss⁃of⁃function mutations of an inhibitory upstream ORF in the human hairless transcript cause Marie Unna hereditary hypotrichosis［J］. Nat Genet, 2009, 41（2）: 228⁃233. DOI: 10.1038/ng.276.
|
| ［2］ |
Zhang SQ, Jiang T, Li M, et al. Exome sequencing identifies MVK mutations in disseminated superficial actinic porokeratosis［J］. Nat Genet, 2012, 44（10）:1156⁃1160. DOI: 10.1038/ng.2409.
|
| ［3］ |
Wolter M, Reifenberger J, Sommer C, et al. Mutations in the human homologue of the Drosophila segment polarity gene patched （PTCH） in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system［J］. Cancer Res, 1997, 57（13）: 2581⁃2585.
|
| ［4］ |
Zhang FR, Huang W, Chen SM, et al. Genomewide association study of leprosy［J］. N Engl J Med, 2009, 361（27）: 2609⁃2618. DOI: 10.1056/NEJMoa0903753.
|
| ［5］ |
Zhang XJ, Huang W, Yang S, et al. Psoriasis genome⁃wide association study identifies susceptibility variants within LCE gene cluster at 1q21［J］. Nat Genet, 2009, 41（2）: 205⁃210. DOI: 10.1038/ng.310.
|
| ［6］ |
Sun LD, Cheng H, Wang ZX, et al. Association analyses identify six new psoriasis susceptibility loci in the Chinese population［J］. Nat Genet, 2010, 42（11）: 1005⁃1009. DOI: 10.1038/ng.690.
|
| ［7］ |
Tang H, Jin X, Li Y, et al. A large⁃scale screen for coding variants predisposing to psoriasis［J］. Nat Genet, 2014, 46（1）: 45⁃50. DOI: 10.1038/ng.2827.
|
| ［8］ |
Han JW, Zheng HF, Cui Y, et al. Genome⁃wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus［J］. Nat Genet, 2009, 41（11）: 1234⁃1237. DOI: 10.1038/ng.472.
|
| ［9］ |
He L, Wu WJ, Yang JK, et al. Two new susceptibility loci 1q24.2 and 11p11.2 confer risk to severe acne［J］. Nat Commun, 2014, 5:2870. DOI: 10.1038/ncomms3870.
|
| ［10］ |
De Rosa L, Carulli S, Cocchiarella F, et al. Long⁃term stability and safety of transgenic cultured epidermal stem cells in gene therapy of junctional epidermolysis bullosa［J］. Stem Cell Reports, 2014, 2（1）: 1⁃8. DOI: 10.1016/j.stemcr.2013.11.001.
|
| ［11］ |
Criscione VD, Weinstock MA. Incidence of cutaneous T⁃cell lymphoma in the United States, 1973⁃2002［J］. Arch Dermatol, 2007, 143（7）: 854⁃859. DOI: 10.1001/archderm.143.7.854.
|
| ［12］ |
Dummer R, Assaf C, Bagot M, et al. Maintenance therapy in cutaneous T⁃cell lymphoma: who, when, what?［J］. Eur J Cancer, 2007, 43（16）: 2321⁃2329.
|
| ［13］ |
Lansigan F, Choi J, Foss FM. Cutaneous T⁃cell lymphoma［J］. Hematol Oncol Clin North Am, 2008, 22（5）: 979⁃996, x. DOI: 10.1016/j.hoc.2008.07.014.
|
| ［14］ |
Kim YH, Chow S, Varghese A, et al. Clinical characteristics and long⁃term outcome of patients with generalized patch and/or plaque （T2） mycosis fungoides［J］. Arch Dermatol, 1999, 135（1）: 26⁃32.
|
| ［15］ |
Zhang Y, Wang Y, Yu R, et al. Molecular markers of early⁃stage mycosis fungoides［J］. J Invest Dermatol, 2012, 132（6）: 1698⁃1706. DOI: 10.1038/jid.2012.13.
|
| ［16］ |
Tian W, Shen J, Zhou M, et al. Dapsone hypersensitivity syndrome among leprosy patients in China［J］. Lepr Rev, 2012, 83（4）: 370⁃377.
|
| ［17］ |
Zhang FR, Liu H, Irwanto A, et al. HLA⁃B*13:01 and the dapsone hypersensitivity syndrome［J］. N Engl J Med, 2013, 369（17）: 1620⁃1628. DOI: 10.1056/NEJMoa1213096.
|
